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Snakebite envenoming is a serious public health problem in Central America, where approximately 5,500 cases
occur every year. Panama has the highest incidence and El Salvador the lowest. The majority, and most severe,
cases are inflicted by the pit viper Bothrops asper (family Viperidae), locally known as ‘terciopelo’, ‘barba amarilla’ or
‘equis’. About 1% of the bites are caused by coral snakes of the genus Micrurus (family Elapidae). Despite significant
and successful efforts in Central America regarding snakebite envenomings in the areas of research, antivenom
manufacture and quality control, training of health professionals in the diagnosis and clinical management of bites,
and prevention of snakebites, much remains to be done in order to further reduce the impact of this medical
condition. This essay presents seven challenges for improving the confrontation of snakebite envenoming in
Central America. Overcoming these challenges demands a coordinated partnership of highly diverse stakeholders
though inter-sectorial and inter-programmatic interventions.
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Introduction
Snakebite envenoming constitutes a serious public health
problem in Central America [1-5]. It has been estimated
that around 5,500 snakebite cases reach health centers
in the region (Figure 1), although it is likely that this
represents an underreporting because, as occurs in
some regions of Asia, Africa and other portions of
Latin America, an unknown number of snake-bitten
people are not treated at health facilities [4]. The absolute
number of accidents, and the corresponding incidence,
varies within the region. Panama has the highest total
number of cases, and its incidence is the highest not only
in Central America, but also in Latin America as a whole
(Table 1). In contrast, the lowest incidence is found in El
Salvador. It is likely that such variations are related to the
exposure of human populations to the species Bothrops
asper, medically the most important snake in the region
(Figure 2). In Panama this pit viper is widely distributed in
centers of high human population density, whereas inCorrespondence: jose.gutierrez@ucr.ac.cr
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unless otherwise stated.El Salvador, located in the dry Pacific corridor of the
region, B. asper is absent [6].
The vast majority of the abundant snake species in
Central America are non-venomous (families Typhlopidae,
Leptotyphlopidae, Anomalepidae, Boidae, Loxocemidae
and Ungaliophidae) [8-10]. Species classified in the family
Colubridae (sensu lato) include snakes with venom glands
and a fang system located in the posterior part of the
maxilla. From the biological standpoint these are venomous
snakes; however, they rarely bite humans, owing mostly to
the difficulty with which they inject their toxic secretions,
and also to the low intrinsic toxicity of some of these
venoms. Hence, signs and symptoms of bites by colubrids
in Central America do not exceed local edema and
bruising [4,11]. In contrast, envenomings that might
be life-threatening are inflicted by snakes classified in the
families Elapidae (yellow-bellied sea snake and coral
snakes) and Viperidae (pit vipers). In the latter, besides
mortality, one serious consequence of envenomings is the
development of permanent sequelae associated with tissue
loss and dysfunction.
Envenomings by pit vipers, among which the most serious
are inflicted by Bothrops asper, locally known as ‘terciopelo’,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Estimated absolute number of snakebite cases in the various Central American countries. These numbers are based on hospital
data. Incidences are presented in Table 1.
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by prominent tissue damage at the bite site involving
pain, edema, blistering, hemorrhage and necrosis of
soft tissues [4,12,13]. In moderate and severe cases,
systemic manifestations occur, characterized mostly by
bleeding, coagulopathy, acute kidney injury, and
cardiovascular shock [4,12,13]. On the other hand,
envenomings by coral snakes (genus Micrurus) present
neurotoxic manifestations provoked by a neuromuscular
blockage predominantly induced by post-synaptically
acting low-molecular-mass neurotoxins [4]. AlthoughTable 1 Estimated total number of cases per year and
incidence of snakebites in the various countries of
Central America
Country Total number of
cases per year
Incidence (per 100,000
inhabitants per year)
Guatemala 600 4.2
Belize 50 15.2
Honduras 600 7.2
El Salvador 50 0.8
Nicaragua 600 10.5
Costa Rica 600 12.9
Panama 2,800 79.8there are no well-described cases of envenomings by the
yellow-bellied sea snake (Pelamis platurus, family Elapidae),
it is likely that they would be associated with neurotoxic
features similar to envenomings by coral snakes [4].
The severity of snakebite envenomings depends on
several factors, namely:
 The volume of venom injected.
 The anatomical site of injection (bites on the head
and trunk tend to be more complicated than those
on the feet or hands).
 The size and physiological condition of the victim
(bites in children tend to be more serious than in
adults).
 Time elapsed between the bite and medical
attention.
The only scientifically validated treatment for snakebite
envenoming is the administration of safe and effective
animal-derived antivenoms [14]. Antivenoms for pit vipers
and coral snakes are manufactured by Instituto Clodomiro
Picado, Universidad de Costa Rica, and distributed to
all Central American countries. In addition, other
antivenoms, manufactured in Mexico and Argentina,
are also available in the region.
Figure 2 Bothrops asper (family Viperidae) is the most
important snake from the medical standpoint in Central
America. It is distributed in the humid tropical lowlands and
provokes the majority of cases, and the most serious ones. It is also
responsible for the majority of fatal cases in the region. This snake
adapts very well to altered environments, such as agricultural fields
and pastures. Photo by Mahmood Sasa and reprinted from
“Confronting the neglected problem of snake bite envenoming: the
need for a global partnership” by Gutiérrez et al., PLOS Medicine,
2006, 3(6), e150 [7]. Creative Commons Attribution License (CCAL).
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public health systems in the region, with the consequent
reduction of mortality in the last decades (see for example
Rojas et al. [15]), a number of challenges remain in Central
America for improving the manner of understanding and
confronting this health issue. The present work discusses
some of these challenges and presents some proposals
for improving the analysis, prevention and treatment
of snakebite envenomings in Central America.
Challenge 1: To improve the knowledge on the
epidemiology and the physical, social and psychological
consequences of snakebite envenomings
There are various studies published on the epidemiology
and mortality of snakebite envenoming in Central America,
especially in Costa Rica [1,15-18]. Likewise, Panamá and
Nicaragua have developed epidemiological surveillance
systems that have provided valuable information on
the incidence and mortality of snakebites in these
countries (Hildaura Acosta and Luz Marina Lozano,
personal communications). Nevertheless, no systematic
information is available on this subject in relation to
Honduras, Guatemala, El Salvador and Belize. Hence,
there is an urgent need to undertake coordinated regional
efforts to gather information on the epidemiological
parameters associated with this condition. It is suggested
that a concerted regional effort, coordinated by the health
ministries in the region and with the support of the
Pan American Health Organization (PAHO), shouldbe promoted to achieve this goal. Once implemented, such
a system will provide updated information of crucial
importance for promoting a knowledge-based system of
decision-making on this subject. Compulsory reporting
of snakebite envenomings has been introduced in
some countries, and needs to be generalized to the
rest of the region.
In addition to the provision of data on incidence and
mortality, this information will allow the identification
of vulnerable regions in each country, particularly with
regard to vulnerable sectors, such as the indigenous
groups. Moreover, there is a need to develop studies of
community-based and household surveys that could
provide a more realistic view of the magnitude of the
problem. This type of research has been undertaken in
other parts of the world, such as Bangladesh and India,
where it showed that the magnitude of this problem is
much larger than what is reflected by hospital-based
statistics [19,20]. Finally, there is an urgent need to gather
information on the incidence of permanent sequelae
in people suffering from snakebite envenoming. This
is a highly neglected aspect of the issue, since people that
survive envenomings usually return to their communities
without following up on the physical and psychological
consequences of these accidents, and their quality-of-life
impact on.
The effect of this disease in specific groups – including
children, indigenous communities, agricultural workers
etc. – should be investigated in order to discern the
particular aspects in which such groups are affected.
The incorporation of social research for understanding
snakebite envenomings and their implications is of
paramount relevance owing to the impact of cultural,
sociological, economical and psychological variables in the
overall picture of this condition [21]. Clearly, research on
public health and other social aspects of snakebite
envenoming in the region is badly needed, through
concerted efforts of ministries of health, research groups
in universities and other institutions, and organizations of
the civil society.
Challenge 2: To improve the knowledge on the clinical
manifestations of envenomings and the response to
antivenom treatment
Since the pioneering work of Clodomiro Picado Twight
[22], a large body of scientific knowledge has been
accumulated on the biology of the venomous snakes
of Central America (see, for example, [1,6,8-10] and
references therein), and on the composition and action
mechanism of snake venoms (see, for example, the special
issue of Toxicon devoted to Bothrops asper in 2009
[23] and a recent review by Lomonte et al. [24] on
the proteomics of venoms of Central American snakes).
Moreover, the technological innovations and improvements
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researchers in the region, as well as the analysis of the
preclinical neutralizing efficacy of antivenoms against the
venoms of Central American snakes (see reviews [25-27]
and references therein). In contrast, there is relatively
little research published on the clinical aspects of
envenomings and on the therapeutic response to antivenoms
[28]. In fact, the most detailed analyses of the efficacy
and safety, in the clinical setting, of antivenoms
manufactured in Costa Rica have been performed in
Colombia, through the studies of Rafael Otero-Patiño
and colleagues [29-32].
There is a need to characterize the clinical manifestations
of envenomings induced by various snakes in the region,
with the aim of identifying clinical patterns characteristic
of some species. Some pending questions in this area are:
 Do envenomings by newborn/neonate and juvenile
pit vipers differ from those provoked by adult
specimens, as suggested by their different proteomic
and toxinological profiles?
 Can bites by Bothriechis sp. species induce
envenomings with systemic manifestations and, if so,
what are these systemic effects?
 What is the clinical picture that characterizes
envenomings by terrestrial species of the genera
Porthidium, Cerrophidium and Atropoides, which
are endemic to Central America?
 Are envenomings by Lachesis stenophrys and
L. melanocephala characterized by the unique
vagal-type effect described in cases by South
American bushmasters?
 Are envenomings by Micrurus sp. characterized only
by neurotoxic manifestations, or do some species
provoke other effects, such as those described in
bites by some South American coral snakes?
Moreover, the therapeutic effect of antivenoms used in
the region in envenomings by different pit viper species
has to be investigated in the clinical setting. It is not
clear, for instance, whether the polyspecific antivenom is
effective, at the clinical level, for neutralizing the venom
of Agkistrodon bilineatus, although preclinical results
may suggest so [33]. Thus, there is a need to develop
partnerships between university research groups and
clinicians to improve the knowledge on snakebite
envenomings and their treatment. In this aspect, the
efforts being carried out in Panama, where strong
links have been established between researchers at the
University of Panamá and a network of clinicians in
various hospitals, constitutes a highly promising step
forward (Hildaura Acosta, personal communication).
It is expected that such efforts will bring novel and
relevant information in the coming years.Challenge 3: To improve the availability and accessibility
of antivenoms in all Central American countries
Antivenoms for the treatment of pit viper and coral
snakebite envenomings have been produced in Costa
Rica since 1967, an effort consolidated by the creation of
Instituto Clodomiro Picado in 1970 [34,35]. In addition,
other manufacturers in Latin America produce antivenoms
that are effective in the treatment of these envenomings
in Central America. Such regional capacity to provide
antivenoms has contributed to antivenom availability
in this region. Moreover, the health ministries and
other institutions of the public health system (such as the
social security systems) have developed purchasing schemes
to obtain these products on a regular basis. Nevertheless,
due to budget constraints, the amount of antivenom
purchased by some countries is insufficient to guarantee
complete coverage of all antivenom needs. On top of this,
the distribution of antivenoms within each country poses
difficult challenges for the public health systems. The lack
of adequate epidemiological information on snakebites in
some countries does not allow for developing knowledge-
based antivenom distribution schemes. Consequently,
antivenoms are often scarce at health clinics in some
rural areas where snakebites are frequent, which has an
impact on the evolution of the cases, since patients need
to be transported to clinics or hospitals in other locations,
with a consequent delay in the onset of treatment.
A relevant challenge in Central America is the buildup
of a solid epidemiological base through which the
health institutions can design a knowledge-based platform
for antivenom distribution. The use of geographical
information system (GIS) tools should help to identify
regions of high vulnerability to snakebites which require
improvements in antivenom deployment (see for example
[36,37] for GIS studies performed in Nicaragua and Costa
Rica) (Figures 3 and 4). Particular attention must be given
to identifying vulnerable regions and groups, such as
indigenous communities and other social and ethnic
groups largely deprived of health services. The analysis
of snakebite cases should be performed vis-à-vis the
distribution of health services, and the distances between
communities and nearest health clinics (see for instance
[37] for the case of Costa Rica) (Figure 4).
In regions of high snakebite incidence where hospitals
or clinics are absent, the allocation of antivenoms to
health posts at the primary-care level should be carefully
considered, through integrated programs ensuring
maintenance of cold chain conditions, appropriate training
of health staff, and provision of antivenoms and other drugs
(including adrenaline, antihistamines and steroids) required
for the management of envenomings. In this regard, and as
a matter of example, proposals for snakebite management
on an integrated national basis have been presented in
Colombia [38] and in Nigeria [39]. A key aspect in these
Figure 3 Incidence of snakebite in Costa Rica per district per 100,000 population (1990-2007). Prepared by Erik Hansson and reprinted
from “Using geographical information systems to identify populations in need of improved accessibility to antivenom treatment for snakebite
envenoming in Costa Rica” by Hansson et al., PLOS Neglected Tropical Diseases, 2013, 7 (1), e2009 [37]. Creative Commons Attribution
License (CCAL).
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qualified staff to primary-care health facilities, thus ensuring
a rapid administration of antivenom to bitten victims.
Depending on the severity and complications of the case,
patients could then be transferred to regional clinics or
hospitals. In Costa Rica, for instance, antivenoms are
distributed to health facilities at various levels of
specialization, such as hospitals, clinics and some centers
at the primary-care level (EBAIS – basic teams of
integrated health attention) [40]. This has contributed
to a reduction in the time lapse between the bite and
the provision of antivenom.
Challenge 4: To ensure the adequate clinical use of
antivenoms
Effective management of snakebite envenomings at the
clinical level demands a proper knowledge on the main
aspects of their clinical manifestations and complications,
diagnosis, and treatment, not only regarding the use of anti-
venom (including the management of adverse reactions),
but also the ancillary therapy of the cases. The acquisition
of this knowledge by health staff requires concerted actionsat various levels, such as university courses in Medicine
and Nursing schools, and permanent education programs,
especially for physicians, nurses and other health staff
working in areas of high incidence of envenomings.
The preparation of national and regional guidelines
is of utmost relevance, in order to ensure a standard
management of these cases with a solid scientific
basis. Significant advances have been made in Panamá
(Hildaura Acosta, personal communication) and Costa Rica,
where snakebite management protocols and algorithms
have been prepared and where permanent teaching
activities take place at universities and health facilities.
Seminars and related activities on the subject are regularly
organized in some countries in the region, but in others
there remains a need to develop permanent training
programs; this demands concerted national and regional
efforts. In this regard, the use of communication and
information technologies, such as those designed for
videoconferences, should be promoted. One example is
the PAHO-supported platform Elluminate, which has
been used for training activities on this subject in
Honduras, Costa Rica and Panamá.
Figure 4 Distribution of hospitals, clinics and ambulance stations in Costa Rica, and estimated time to reach hospitals or clinics in
various regions of the country. As shown in Figure 3, regions where transportation to health facilities takes longer correspond to regions of
high snakebite incidence. Prepared by Erik Hansson and reprinted from Hansson et al. [37].
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suffering from sequelae of snakebite envenomings
One of the most neglected aspects of snakebite
envenoming is following up on accident victims who
develop permanent physical or psychological sequelae,
especially those resulting from cases of viperid snakebites.
The actual incidence of these sequelae is largely unknown,
because survivors leave the hospital and follow-up of these
cases is not performed. Since these accidents mostly affect
poor and vulnerable people living in rural areas, the
impact in their quality of life is likely to be dramatic.
On one hand, this greatly affects their physical integrity
and, consequently, their ability to perform field work, thus
contributing to the vicious cycle of poverty. In addition,
the psychological consequences of such a traumatic
event are likely to be high, as demonstrated in a study on
snakebite victims performed in Sri Lanka [41].
There is a pressing need to study the magnitude and
characteristics of this problem in the region through
integrated and interdisciplinary research projects. The
relevance of social research in this aspect of the
snakebite problem cannot be overestimated. The informa-
tion generated in such studies will serve as the basis forthe development of interventions by governmental and
non-governmental groups with the aim of alleviating the
long-term consequences of envenomings. The examples
in which non-governmental organizations of the civil
society have been created to improve the management
of many diseases and mitigate their impact on the affected
population, should serve to stimulate not only learning
but also the development of similar organizations in
support of snakebite victims.
Challenge 6: To improve the prevention of snakebites
Information gathered on the epidemiology of snakebite
envenomings in Central America highlights several trends
that are very helpful in designing effective prevention
campaigns. The majority of accidents occur in the rural
population in people devoted to agricultural work; hence,
priority attention should be given to the provision of basic
information on preventive measurements in these groups
and communities. To this end, it is relevant to work in
close coordination with local community organizations,
in order to design the most appropriate intervention
programs, which should be tailored to the specific cultural
and social features of the populations. One important case
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appropriately designed campaigns must be prepared in
local languages and should be adapted to the world view
of these groups. In Costa Rica, for instance, Instituto
Clodomiro Picado and Caja Costarricense del Seguro
Social have developed a prevention program for the
communities of the Cabécar ethnic group inhabiting the
Caribbean region; this program was developed in close
collaboration with the communities and with health and
educational institutions in the region [42] (Figure 5).
Most of the snakebites in Central America occur on
the feet (~50%) and hands (~30%) [1,4]. Therefore, the
promotion of basic prevention measures should include
the use of footwear and of sticks to test the ground
before using the hands in agricultural duties. Moreover,
using a torch after sunset and keeping the areas
surrounding houses cleaned in regions of high abundance
of snakes, especially Bothrops asper, are measures that
reduce the likelihood of an accident. Finally, but not
less important, is the community-based organization
of rapid transportation of bitten people to the nearest
health center. It is well known that the prognosis ofFigure 5 Cover of a publication used in education campaigns
to promote the prevention of snakebites in indigenous
communities of the Cabécar ethnic group in Costa Rica. This
material was prepared in the Spanish and Cabécar languages by a
cooperative project coordinated by Dr. Laura Monturiol (Instituto
Clodomiro Picado) and developed by Instituto Clodomiro Picado
(Universidad de Costa Rica), Caja Costarricense del Seguro Social, the
Ministry of Education, and the Cabécar people. It was widely
distributed in the Cabécar communities and used in local schools as
part of a prevention campaign [42]. Serpientes de Costa Rica y
prevención de mordeduras: Guía de información, 2009, Instituto
Clodomiro Picado, Facultad de Microbiología, Universidad de Costa
Rica. Reprinted approved by the General Director of the Institute.an envenoming is directly related to the time lapse
between the bite and the onset of treatment. Therefore,
avoiding unnecessary delays due to the performance of
ineffective and often harmful first aid interventions, and
ensuring rapid transportation to the health post are key
components of an adequate strategy to confront this
problem. In Nepal, for instance, an effective motor-
cycle transportation system, together with community
education campaigns, has proven highly effective at
reducing the incidence and mortality due to snakebite
envenomings [43].
Challenge 7: To raise awareness of the relevance of
snakebite envenoming in politicians and in the general
population
The confrontation of snakebite envenoming as a public
health problem on a global basis has been greatly
hampered by its systematic neglect among public
health and political authorities [7,44,45]. The fact that
snakebite is not an infectious or parasitic disease has
contributed to its alienation from the mainstream of
international strategies to confront neglected tropical
diseases [44,45]. Likewise, at the national level, a
number of factors, such as poor epidemiological
information, lack of a political voice representing the
affected population, weak advocacy efforts by researchers,
health promoters and community organizations, and
little interest from the pharmaceutical sector, have
largely contributed to the invisibility of this serious
medical condition.
This scenario should be overcome by a concerted
advocacy program at various levels. On a worldwide basis,
one of the main goals of the Global Snakebite Initiative
(GSI –www.snakebiteinitiative.org) is to promote the
global awareness of the impact of snakebite envenomings
[45]. Coordinated efforts have to be performed at regional
and national levels as well. Of greatest relevance is the
permanent communication with public health political
authorities, mostly ministries of health, in order to
upgrade the status of snakebite envenoming on the public
health agenda. In Central America, this should result in
the inclusion of discussions on snakebites at the regional
meetings of ministers and in the design of coordinated
actions in the region. To attain this goal, it is necessary
to forge alliances between diverse groups, such as
academics, health professionals, public health promoters
and community-based organizations. It is only through
the concerted efforts of such a wide array of stakeholders
that this problem is going to receive proper attention. The
inclusion of snakebite envenoming within the national
and regional plans to combat neglected tropical diseases
should be emphasized, by its incorporation in the
packages designed for tropical infectious diseases, thus
optimizing the use of resources [45].
Gutiérrez Journal of Venomous Animals and Toxins including Tropical Diseases 2014, 20:7 Page 8 of 9
http://www.jvat.org/content/20/1/7Conclusion
As observed in many regions of Africa, Asia, Latin
America and Oceania, snakebite envenomings represent
a serious public health problem in Central America.
Although valuable efforts have been made in the region
to perform research on snakes, venoms, and envenomings,
to train health professionals and students in the details of
the clinical diagnosis and management of envenomings, to
produce and distribute safe and effective antivenoms
to all the countries, and to promote the prevention of
snakebites – much remains to be done in order to reduce
the impact of this medical condition. The challenges
discussed in this work present some of the issues that
should be considered. Of highest relevance is the need to
incorporate stakeholders from a wide spectrum of sectors
in the study and solution of the problems associated with
snakebites. It is only through concerted inter-programmatic
and inter-sectorial interventions by diverse actors that the
heavy impact of human suffering inflicted by this condition
will be significantly reduced.
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